<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Uto M</submitter><funding>Japan Society for the Promotion of Science London</funding><pagination>987-994</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9529683</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(10)</volume><pubmed_abstract>The prognosis of patients with brain metastases has dramatically improved, and long-term tumor control and reduction of the risk of late toxicities, including neurocognitive dysfunction, are important for patient quality of life. Stereotactic irradiation for multiple brain metastases, rather than whole-brain radiotherapy, can result in high local control rate with low incidence of neurocognitive deterioration and leukoencephalopathy. Recent advances in radiotherapy devices, treatment-planning systems, and image-guided radiotherapy can realize single isocenter stereotactic irradiation for multiple brain metastases (SI-STI-MBM), in which only one isocenter is sufficient to treat multiple brain metastases simultaneously. SI-STI-MBM has expanded the indications for linear accelerator-based stereotactic irradiation and considerably reduced patient burden. This review summarizes the background, methods, clinical outcomes, and specific consideration points of SI-STI-MBM. In addition, the prospects of SI-STI-MBM are addressed.</pubmed_abstract><journal>Japanese journal of radiology</journal><pubmed_title>Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects.</pubmed_title><pmcid>PMC9529683</pmcid><funding_grant_id>21K15548</funding_grant_id><pubmed_authors>Mizowaki T</pubmed_authors><pubmed_authors>Uto M</pubmed_authors><pubmed_authors>Torizuka D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects.</name><description>The prognosis of patients with brain metastases has dramatically improved, and long-term tumor control and reduction of the risk of late toxicities, including neurocognitive dysfunction, are important for patient quality of life. Stereotactic irradiation for multiple brain metastases, rather than whole-brain radiotherapy, can result in high local control rate with low incidence of neurocognitive deterioration and leukoencephalopathy. Recent advances in radiotherapy devices, treatment-planning systems, and image-guided radiotherapy can realize single isocenter stereotactic irradiation for multiple brain metastases (SI-STI-MBM), in which only one isocenter is sufficient to treat multiple brain metastases simultaneously. SI-STI-MBM has expanded the indications for linear accelerator-based stereotactic irradiation and considerably reduced patient burden. This review summarizes the background, methods, clinical outcomes, and specific consideration points of SI-STI-MBM. In addition, the prospects of SI-STI-MBM are addressed.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-05-29T16:10:27.499Z</modification><creation>2025-04-07T12:25:20.285Z</creation></dates><accession>S-EPMC9529683</accession><cross_references><pubmed>36057071</pubmed><doi>10.1007/s11604-022-01333-7</doi></cross_references></HashMap>